News
Roche stock rises on study of new lung cancer drug
23+ min ago (174+ words) medwatch. com Stay ahead of development by receiving our newsletter on the latest sector knowledge. Roche stock rises on study of new lung cancer drug In the study, Roche's drug candidate divarasib was shown to prolong patient survival compared with…...
US launches security probe five pharma giants doing clinical trials in China
3+ hour, 17+ min ago (212+ words) medwatch. com Stay ahead of development by receiving our newsletter on the latest sector knowledge. US launches security probe five pharma giants doing clinical trials in China MSD, Abb Vie, Eli Lilly, Pfizer, and Bristol Myers Squibb must provide an…...
Novo Nordisk seeks extraordinary discounts from suppliers
6+ hour, 59+ min ago (137+ words) medwatch. com Stay ahead of development by receiving our newsletter on the latest sector knowledge. Novo Nordisk seeks extraordinary discounts from suppliers Novo Nordisk's approach is criticized by a Danish business organization, which calls it "bordering on bullying. Novo Nordisk…...
Swiss Galderma takes a hit after FDA rejection
1+ day, 23+ min ago (54+ words) medwatch. com The Swiss skincare company Galderma took a hit on the stock market on Wednesday after the US Food and Drug Administration (FDA) rejected Relfydess, a competing treatment to the better-known Botox. Global Clinical Lead, Clinical Development, Migraine & Pain…...
Anthropic launches AI initiative for life sciences
23+ hour, 37+ min ago (153+ words) medwatch. com Anthropic launches AI initiative for life sciences Novo Nordisk and other pharmaceutical companies are already using the company's AI tools for purposes such as research and regulatory submissions. The US tech company Anthropic has launched Claude Science, an…...
Ipsen acquires Swiss-based Memo Therapeutics
1+ day, 5+ hour ago (159+ words) medwatch. com Stay ahead of development by receiving our newsletter on the latest sector knowledge. Ipsen acquires Swiss-based Memo Therapeutics The deal could end up costing the French company more than EUR 700m. The French pharmaceutical company Ipsen is acquiring Memo…...
Life science stakeholders want action from European leaders
1+ day, 5+ hour ago (163+ words) medwatch. com Stay ahead of development by receiving our newsletter on the latest sector knowledge. Life science stakeholders want action from European leaders Europe is finding it increasingly difficult to scale up and retain the most promising life sciences companies,…...
Eli Lilly selected for US program to speed review of new manufacturing plants
2+ day, 1+ hour ago (54+ words) medwatch. com On Monday, Eli Lilly was selected by US health authorities to participate in a pilot project aimed at accelerating and expanding drug production. Specialist, Global Health Policy Global Clinical Lead, Clinical Development, Migraine & Pain Head of Data Science...
Genmab reports promising data from new cancer study
2+ day, 2+ hour ago (196+ words) medwatch. com Genmab reports promising data from new cancer study Genmab will now discuss the results of the epcoritamab study with regulatory authorities, together with its partner Abb Vie. In a phase 3 study of the cancer treatment epcoritamab in combination…...
Healthcare personnel and external vendors affected by Novo cyberattack
2+ day, 5+ hour ago (141+ words) medwatch. com Stay ahead of development by receiving our newsletter on the latest sector knowledge. Healthcare personnel and external vendors affected by Novo cyberattack Previously, it was reported that the individuals affected by the incident were participants in clinical trials....